IHDR that is some truly great information. However, I think what many investors have to realize is that this company is a Biotech in phase III for the most part. They know the process works but now they have to formulate the right combination for effective Hydrogen production with maximum yield. There is no sense putting out numbers unless its the best they feel they can achieve. With regards to the scientific vs financial speak, that will take care of itself...we just hired a marketing guy with tie-ins to the BIGS. Remember these PRs are as much for information dispersal to investors as they are for marketing to potential BIGS. This to me is not a trading stock.